Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Iron deficiency is not a significant cause of hair loss in women.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride reduces hair growth and is safe for women with excessive hair.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document concludes that supportive home environments and addressing parent-child interactions can effectively treat trichotillomania in children.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.